CN1428156A - Capsule for curing aplastic anemia and its production method - Google Patents
Capsule for curing aplastic anemia and its production method Download PDFInfo
- Publication number
- CN1428156A CN1428156A CN01138358A CN01138358A CN1428156A CN 1428156 A CN1428156 A CN 1428156A CN 01138358 A CN01138358 A CN 01138358A CN 01138358 A CN01138358 A CN 01138358A CN 1428156 A CN1428156 A CN 1428156A
- Authority
- CN
- China
- Prior art keywords
- radix
- liquid
- aplastic anemia
- powder
- milliliter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese medicine capsule preparation for curing aplastic anemia. It is made up by using 6 Chinese medicinal materials of (by weight portion) 3 portions of notoginseng, 3 portions of amomum fruit, 1 portion of deerhorn glue, 5 portions of Chinese angelica root, 3 portions of coored rhubarb and 10 portions of astragalus root through the processes of separate pulverizing, decoction, concentration, filtering, alcohol extraction, recovering alcohol, concentration, precipitation, drying, mixing and capsulizing to obtain finished product with obvious therapeutic effect. Its effective rate is up to above 90%, and its effectual rate is up to above 60%, and for curing acute aplastic anemia its effective rate is up to 75%.
Description
(1) technical field
The present invention relates to a kind of capsule and production technology that is used for the treatment of aplastic anemia, it is a kind of with the multi-flavor natural Chinese medicinal herb, the capsule that adopts extraction process to be prepared from.
(2) background technology
Present aplastic anemia is the stubborn disease of comparatively common and refractory in the hematopathy, and mortality rate is high, still belongs to difficulty both domestic and external and attacks problem.Doctor trained in Western medicine is with treatments such as immunosuppressant, glucocorticoid, androgen and blood transfusions, though part patient can postpone separating symptom, but decrement along with hormone drug, symptom is serious again to be occurred, its more caused side effect is worrying, as 27 kinds of side effect such as femur head necrosis, endocrine disturbance, diabetes, digestive tract ulcer, immunologic function are lower than, spend highly, more the back property is poor.
The objective of the invention is a kind of capsule and production method that is used for the treatment of aplastic anemia of developing at above deficiency, it is a kind of capsule that adopts extraction process to be prepared into the multi-flavor natural Chinese medicinal herb.This medicine with traditional Chinese medical science warming and recuperating the spleen and kidney, beneficial marrow hemopoietic, removing stasis to stop bleeding, dampness is eliminating evil is theoretical basis, with Radix Astragali invigorating the spleen and benefiting QI is monarch, Radix Angelicae Sinensis, Colla cornus cervi benefit marrow hemopoietic are minister, Radix Et Rhizoma Rhei, Radix Notoginseng blood stasis dispersing and fresh blood promoting, cooling blood for hemostasis, the Fructus Amomi removing dampness of being amusing, it is eliminating evil altogether for assistant makes to regulate the flow of vital energy, and gathers the effect of strengthening vital QI to eliminate pathogenic factors altogether.
(3) summary of the invention
The object of the present invention is achieved like this, and the capsule raw material that is used for the treatment of aplastic anemia is 3 parts of Radix Notoginseng, 3 parts of Fructus Amomis, 1 part of Colla cornus cervi, 5 parts of Radix Angelicae Sinensis, 3 parts of Radix Et Rhizoma Rhei, 10 parts of the Radixs Astragali.
The raw material processing procedure of this product is, Radix Et Rhizoma Rhei, the Radix Astragali, Fructus Amomi, Radix Angelicae Sinensis are followed an example to do, and mixes to fry in shallow oil juice and decoct altogether three times, merges three times decocting liquid, be concentrated into every milliliter and contain primary dose 1 and restrain, and alcohol extraction then, it is standby to be condensed into cream; Again Radix Notoginseng is followed an example to do and to be ground into powder standby for Colla cornus cervi.
Aplastic anemia belongs to traditional Chinese medical science mass formed by blood stasis, category such as deficient.Its etiology and pathogenesis is owing to diseases caused by exogenous pathogenic factor six climate exopathogens, pestilential pathogen virus, internal injury caused by excess of seven emotions, damages healthy energy and impairment of the spleen kidney, and the essence of suffering from a deficiency of the kidney is not changed blood, deficiency of spleen-QI, flaccidity of the limbs then, the five internal organs uneasiness is because of the spleen being the foundation of acquired constitution, dysfunction of the spleen in transportation, interior living damp causes fluffy of all diseases such as prolonged low grade fever, hemorrhage, moving blood.Miraculous Pivot is said: " injury of YANG-collateral leading to outwards bleeding also, injury of YIN collateral leading to inner bleeding also " caused the function disorder, the negative and positive of qi and blood imbalance.Simultaneously to the anemia of aplastic anemia, hemorrhage, heating, infect the summary that has given height.
According to motherland's theory of medicine, developed eliminating evil Hematogenesis capsule, its mechanism of action is: warming and recuperating the spleen and kidney, beneficial marrow hemopoietic, enhance immunity, removing stasis to stop bleeding, dehumidifying are eliminating evil, medicine are not hindered clearly just mending not give birth to heat, reach the purpose of curing aplastic anemia.Radix Astragali invigorating the spleen and benefiting QI is monarch in the side, and Radix Angelicae Sinensis, Colla cornus cervi benefit marrow hemopoietic is a minister, Radix Et Rhizoma Rhei, Radix Notoginseng blood stasis dispersing and fresh blood promoting, removing heat from blood, hemostasis, and the purpose of setting upright method heresy, treating both the principal and secondary aspects of a disease is gathered in Fructus Amomi removing dampness, eliminating evil for assistant makes altogether.
The capsule manufacture method that the present invention is used for the treatment of aplastic anemia is: the first step follows an example to do the Radix Astragali, Radix Angelicae Sinensis, Fructus Amomi, Radix Et Rhizoma Rhei; Four Chinese medicine after second step concocted mixes fries in shallow oil juice, fries in shallow oil altogether three times, boils 30 minutes at every turn, removes medicinal residues, and merging three decocting liquids is A liquid; The 3rd step evaporation A liquid is concentrated into every milliliter of concentrated solution that contains primary dose 1 gram, 95% the ethanol that adds 1 times of amount again, the placement precipitation that stirs was filtered in 12 hours, then filtrate concentrating under reduced pressure, recovery ethanol, made every milliliter of medicinal liquid contain primary dose 4-6 gram and was B liquid; The 4th step became every milliliter to contain primary dose 1 gram and staticly settled 12 hours B liquid thin up, precipitated liquid was filtered again, and then filtrate was condensed into cream, and it is standby that concentration proportion is about 1.2-1.6; The 5th the step Radix Notoginseng is followed an example to do, with Colla cornus cervi pulverize into powder standby; The 6th step was got the 4th step condensed cream, added the 5th step Chinese drugs powder and mixed, and added appropriate amount of starch again to full dose, made the powder of this product, placed temperature 60-70 degree centigrade baking room dry, and mixing divides encapsulated then.
Good effect of the present invention is:
1, these product flavour of a drug are simple, have no side effect, and are cheap, taking convenience, and a day dosing only is equivalent to
Primary dose 25 grams have been saved the medicine source.
2, the production technology of this product is adopt to pulverize to decoct, concentrate, alcohol extraction, recovery, merging, oven dry,
Be made as capsule.
3, this product reaches more than 90% the treatment effective percentage of aplastic anemia, and obvious effective rate reaches more than 60%.
4, this product has reinforcing spleen and kidney, and removing stasis to stop bleeding reaches more than 75% the acute aplastic anemia effective percentage.
5, this product has the obvious microcirculatory effect of bone marrow hematogenesis that improves through the animal effect experiment.Take this product
Hematochrome, platelet, leukocyte, net are knitted the red rising that has in various degree after the product 1-2 month.
6, this product is made up of Fructus Amomi, Colla cornus cervi, Radix Angelicae Sinensis, Radix Notoginseng, Radix Et Rhizoma Rhei, the Radix Astragali.Its Quality Control is adopted
Thin layer chromatography is the quality standard of this medicine.
(4) specific embodiment
Below to produce 1000 capsules and to be that the present invention is described in further detail for example with the concrete condition of this capsule for treating aplastic anemia:
The first step with Radix Astragali 400g, Radix Et Rhizoma Rhei 120g, Radix Angelicae Sinensis 200g, Fructus Amomi 120g, follow an example to do; The Radix Astragali after second step concocted, Radix Et Rhizoma Rhei, Radix Angelicae Sinensis, Fructus Amomi four Chinese medicine mix fries in shallow oil juice, fries in shallow oil altogether three times, boils 30 minutes at every turn, and merging three medicinal liquids is A liquid; The 3rd step evaporation A liquid is concentrated into every milliliter of ethanol that contains 1 times of amount 95% of concentrated solution adding of primary dose 1 gram and stirs, place precipitation filtered in 12 hours, and then, make every milliliter of medicinal liquid contain primary dose 4-6 gram and be B liquid filtrate concentrating under reduced pressure recovery ethanol; The 4th step became every milliliter to contain primary dose 1 gram and staticly settled 12 hours B liquid thin up, precipitated liquid was filtered again, and then filtrate was condensed into cream, and concentrated proportion is that 1.2-1.6 is standby; The 5th the step Radix Notoginseng is followed an example to do, with Colla cornus cervi pulverize into powder standby; The 6th step got the 4th step condensed cream and adds the 5th step Chinese drugs powder, mix homogeneously makes the powder of this product, place temperature 60-70 degree centigrade baking room dry, mix then, add an amount of starch to 300 gram again, mixing makes the powder of this product, and dividing encapsulated then both had been 1000 capsules that are used for the treatment of aplastic anemia.
The present invention is used for the treatment of the aplastic anemia model case:
Model case 1
Patient Kong Lingmei, the woman, 28 years old, in Huaiyang, Henan one, in January nineteen ninety in Zhengzhou, Beijing is diagnosed as heavy aplastic anemia (SAA), all invalid through how tame hospitalize, October in the same year, come Zhoukou City combination of Chinese and Western medicine hematopathy hospital, patient's clinical manifestation is: shallow complexion, unable, appetite is poor, nervous cardiopalmus, dizziness and blurred vision, heating, ecchymosis and petechia, light red tongue, yellow fur, deep pulse number, hemogram: hematochrome 2.7g/L, platelet 11 * 10
9/ L, leukocyte 0.9 * 10
9/ L, N:0.14, L:0.86, bone marrow smear: nucleated cell hypertrophy severe is low.Oral capsule of the present invention does not have blood transfusion and waits 27 days, and hematochrome returns to 7.5g/L, leukocyte 1.8 * 10
9/ L, platelet 32 * 10
9/ L continued again to take medicine 28 days, and it is normal that hematochrome recovers, and after taking medicine five months, hemogram, bone marrow smear check that all are normal, follow up a case by regular visits to healthy in 11 years.(0394-2666108)
Model case 2
Patient Niu Xingwei, the man, 40 years old, the section chief of institute was checked in Miyang, Henan, in February, 1999 in Zhengzhou, Beijing is diagnosed as PRCA, companion's nephritis.The Ceng Duojia hospitalize is invalid, and has descended the notice of being critically ill three times, on July 20th, 1999, comes Zhoukou City combination of Chinese and Western medicine hematopathy hospital.Patient's clinical manifestation is: the yellowish complexion edema, breathe hard, have palpitation, be off one's feed, heating, pale tongue, yellow and greasy fur, hemogram: hematochrome 3.7g/L, leukocyte 4.0 * 10
9L, platelet 85 * 10
9L, oral capsule of the present invention, antiinflammatory does not have blood transfusion etc.After one month, hematochrome rises to 8.5g/L leaves hospital, and continues again to take medicine three months, and give check: all are normal for hemogram, bone marrow smear, go on work position again in January, 2000, and are healthy so far.
(0396-7926856、13938362630)
Claims (2)
1, a kind of capsule that is used for the treatment of aplastic anemia is characterized in that:
The raw material of a, this product is:
3 parts of Radix Notoginseng, 3 parts of Fructus Amomis, 1 part of Colla cornus cervi, 5 parts of Radix Angelicae Sinensis, 3 parts of Radix Et Rhizoma Rhei, 10 parts of the Radixs Astragali
The raw material processing procedure of b, this product is, Radix Et Rhizoma Rhei, the Radix Astragali, Fructus Amomi, Radix Angelicae Sinensis are followed an example to do, and mixes to fry in shallow oil juice and decoct altogether three times, merges three times decocting liquid, be concentrated into every milliliter and contain primary dose 1 and restrain, and alcohol extraction then, it is standby to be condensed into cream; Again Radix Notoginseng is followed an example to do and to be ground into powder standby for Colla cornus cervi.
2, a kind of capsular production method of aplastic anemia that is used for the treatment of is: the first step follows an example to do the Radix Astragali, Radix Angelicae Sinensis, Fructus Amomi, Radix Et Rhizoma Rhei; Four Chinese medicine after second step concocted mixes fries in shallow oil juice, fries in shallow oil altogether three times, boils 30 minutes at every turn, removes medicinal residues, and merging three decocting liquids is A liquid; The 3rd step evaporation A liquid is concentrated into every milliliter of concentrated solution that contains primary dose 1 gram, 95% the ethanol that adds 1 times of amount again, the placement precipitation that stirs was filtered in 12 hours, then filtrate concentrating under reduced pressure, recovery ethanol, was B liquid though make every milliliter of medicinal liquid contain crude drug in whole 4-6 gram; The 4th step added cold water with B liquid and is diluted to every milliliter of primary dose 1 gram, staticly settled 12 hours, precipitated liquid was filtered again, and then filtrate was condensed into cream, and it is standby that concentration proportion is about 1.2-1.6; The 5th step followed an example to do Radix Notoginseng, was that powder is standby with Colla cornus cervi powder essence; The 6th step was got the 4th step condensed cream, added in the 5th step Chinese drugs powder to mix, and added appropriate amount of starch again to full dose, made the powder of this product, placed temperature 60-70 degree centigrade baking room dry, and mixing divides encapsulated then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011383585A CN1186038C (en) | 2001-12-25 | 2001-12-25 | Capsule for curing aplastic anemia and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011383585A CN1186038C (en) | 2001-12-25 | 2001-12-25 | Capsule for curing aplastic anemia and its production method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1428156A true CN1428156A (en) | 2003-07-09 |
| CN1186038C CN1186038C (en) | 2005-01-26 |
Family
ID=4674559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011383585A Expired - Fee Related CN1186038C (en) | 2001-12-25 | 2001-12-25 | Capsule for curing aplastic anemia and its production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1186038C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496637A (en) * | 2017-10-25 | 2017-12-22 | 沈瑞金 | A kind of Chinese medicine for treating acute aplastic anemia |
| CN108567951A (en) * | 2018-08-01 | 2018-09-25 | 河南中医药大学 | It is a kind of to treat hemopathic Chinese medicine composition and preparation method thereof |
| CN108635541A (en) * | 2018-08-01 | 2018-10-12 | 河南中医药大学 | It is a kind of to treat hemopathic Chinese medicine |
-
2001
- 2001-12-25 CN CNB011383585A patent/CN1186038C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496637A (en) * | 2017-10-25 | 2017-12-22 | 沈瑞金 | A kind of Chinese medicine for treating acute aplastic anemia |
| CN108567951A (en) * | 2018-08-01 | 2018-09-25 | 河南中医药大学 | It is a kind of to treat hemopathic Chinese medicine composition and preparation method thereof |
| CN108635541A (en) * | 2018-08-01 | 2018-10-12 | 河南中医药大学 | It is a kind of to treat hemopathic Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1186038C (en) | 2005-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1330347C (en) | Gongbu ointment | |
| WO2007009291A1 (en) | A pharmaceutical composition of traditional chineses medicine for treating rheumatoid arthritis and preparation thereof | |
| CN102225138B (en) | Traditional Chinese medicine composition for treating fracture and preparation method and application thereof | |
| CN100589838C (en) | Acne treating Chinese herbal medicine preparation | |
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN1824009A (en) | Multipurpose medicinal composition capable of oral administration and external use | |
| CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
| CN102462827A (en) | Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat | |
| CN101890062B (en) | Use of nardostachys chinensis batal and extract thereof in preparation of medicaments for treating gastric ulcer | |
| CN1186038C (en) | Capsule for curing aplastic anemia and its production method | |
| CN1077896A (en) | Medicine for psoriasis and manufacture method | |
| CN104644967A (en) | Pharmaceutical composition for treating I-type diabetes and application thereof | |
| CN1440804A (en) | Antilipemic Chinese medicine | |
| CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
| CN1212149C (en) | Cinese material medical preparation for curing children' hyperkinetic symptom and the preparation process thereof | |
| CN1236804C (en) | Making method of capsule for treating hemorrhoid | |
| CN1314160A (en) | Oral pill for curing diabetes and its complication | |
| CN1063074C (en) | Chinese herbs injection for treating oncoma (cancer) and preparation method | |
| CN105878716A (en) | Chinese herbal medicine compound preparation for preventing and treating chicken hydropericardium syndrome | |
| CN1317003C (en) | Capsule comprising oriental cattail pollen and red sange root and technique for preparing the same | |
| CN106389702A (en) | Traditional Chinese medicine for recovering symptoms of gynecological and obstetric surgery and preparation method of traditional Chinese medicine | |
| CN106729101B (en) | Traditional Chinese medicine composition for treating post-circulation ischemic stroke and preparation method thereof | |
| CN104107351A (en) | Chinese herbal medicine for blood fat reducing, and administration method thereof | |
| CN1194722C (en) | Shugan Zhitong soft extract for treating hepatitis | |
| CN105106817A (en) | Yao medicine compound broadleaf globethistle inflorescence tablet for treating diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050126 Termination date: 20101225 |